Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Drug Discovery Today

• Publication date

  2004-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1359-6446(04)03280-5PMID 15574318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Strategies for dealing with metabolite elucidation in drug discovery and development.

  2004cited by this paper
• Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans

  2004cited by this paper
• Strategies for dealing with reactive intermediates in drug discovery and development.

  2004cited by this paper
• Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.

  2003cited by this paper
• Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.

  2003cited by this paper
• Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

  2003cited by this paper
• Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.

  2003cited by this paper
• Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry.

  2003cited by this paper
• Timing of New Black Box Warnings and Withdrawals for Prescription Medications

  2003cited by this paper
• Online hydrogen-deuterium exchange and a tandem-quadrupole time-of-flight mass spectrometer coupled with liquid chromatography for metabolite identification in drug metabolism.

  2003cited by this paper
• Screening for the potential of a drug candidate to cause idiosyncratic drug reactions.

  2003cited by this paper
• Metabolite identification in drug discovery.

  2003cited by this paper
• Computer systems for the prediction of toxicity: an update.

  2002cited by this paper
• Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process.

  2002cited by this paper
• Timing of new black box warnings and withdrawals for prescription medications.

  2002cited by this paper
• Quantitative Structure–Activity Relationships in Drug Design

  2002cited by this paper
• Accelerating the drug optimization process: identification, structure elucidation, and quantification of in vivo metabolites using stable isotopes with LC/MSn and the chemiluminescent nitrogen detector.

  2002cited by this paper
• Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity.

  2002cited by this paper
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist.

  2001cited by this paper
• An ABC of Drug-Related Problems

  2000cited by this paper
• Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.

  2000cited by this paper
• Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans

  2000cited by this paper
• Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

  1999cited by this paper
• Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.

  1998cited by this paper
• Adverse drug reactions

  1998cited by this paper
• Discovery of bioavailable inhibitors of secretory phospholipase A2.

  1998cited by this paper
• Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy.

  1998cited by this paper
• Fortnightly review: Adverse drug reactions

  1998cited by this paper
• Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.

  1998cited by this paper
• Structure-based methods for predicting mutagenicity and carcinogenicity: are we there yet?

  1998cited by this paper
• Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.

  1997cited by this paper
• Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.

  1997cited by this paper
• Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay.

  1997cited by this paper
• Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime.

  1997cited by this paper
• Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime

  1997cited by this paper
• Rapid Commun. Mass Spectrom.10. 1629-1637 (1996) Matrix-assisted Laser Desorption/Ionisation Mass Spectrometry in Milk Science

  1997cited by this paper
• Synthesis and Bioactivity of Novel Bis(heteroaryl)piperazine (BHAP) Reverse Transcriptase Inhibitors: Structure-Activity Relationships and Increased Metabolic Stability of Novel Substituted Pyridine Analogues.

  1997cited by this paper
• Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships and increased metabolic stability of novel substituted pyridine analogs.

  1996cited by this paper
• Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective

  1995cited by this paper
• Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.

  1992cited by this paper
• Quantitative structure--activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character.

  1977cited by this paper
• Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

  1977cited by this paper

• Design and development of 1,5-diarylpyrazole-based multitarget-directed ligands as dual COX-2/HDAC6 inhibitors for Alzheimer's disease therapy: Molecular dynamics and experimental insights.

  2026cites this paper
• Structure-guided design and synthesis of selective butyrylcholinesterase inhibitors

  2026cites this paper
• Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors.

  2025cites this paper
• Multicomponent synthesis, insecticidal evaluation and molecular dynamics studies of new nicotinonitrile derivatives bearing pyrazole or triazole moieties.

  2025cites this paper
• UHPLC-QTOF-MS/MS metabolomic profiling and in silico-in vivo evaluation of Gliricidia sepium leaves for renoprotection in diabetic nephropathy.

  2025cites this paper
• MetaboGNN: predicting liver metabolic stability with graph neural networks and cross-species data

  2025cites this paper
• Design and Synthesis of 2-anilinopyrimidine Analogues as Dual Inhibitors of CDK9 and CDK12 for cancer therapy: Biological Evaluation and Computational Studies

  2025cites this paper
• Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review

  2025cites this paper
• Anti-inflammatory and cytotoxic assessment of flavonoids isolated from Viola odorata flowers with computer-guided docking study

  2025cites this paper
• Antifungal potential of Lactobacillus bioactive metabolites: synergistic interactions with food preservatives and molecular docking insights

  2025cites this paper
• Design, synthesis, and molecular modeling of new 1,2,4-triazole-containing indole compounds as aromatase antagonists for the treatment of breast cancer.

  2025cites this paper
• Rationale design, synthesis and antimicrobial activity of benzimidazole-pyridinecarbonitrile conjugates: Insights into ROS-induced oxidative damage and molecular dynamics simulations.

  2025cites this paper
• Desulfurizative Fluorination of N‐CF3 Thioformamides for the Efficient Synthesis of N(CF3)(CF2H) Amines with Enhanced Stability

  2025cites this paper
• A Photocatalytic Approach to Radical 1-(Trifluoromethyl)cyclopropanation

  2025cites this paper
• Recent advances in CDC7 kinase inhibitors: Novel strategies for the treatment of cancers and neurodegenerative diseases.

  2025cites this paper
• Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines

  2025cites this paper
• Synthesis of Isatin-Schiff Base and 1,2,3-Triazole Hybrids as Anti-SARS-CoV-2 Agents: DFT, Molecular Docking, and ADMET Studies

  2025cites this paper
• Development of Some Derivatives of Pyrimidine-5-carbonitrile as Inhibitors of PI3K and Screening of Their Anticancer Activity

  2025cites this paper
• Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS‐CoV‐2

  2025cites this paper
• The Role of Small Molecules Containing Fluorine Atoms in Medicine and Imaging Applications

  2024cites this paper
• Facile and Novel Synthetic Approach, Molecular Docking, Molecular Dynamics, and Drug‐Likeness Evaluation of 9‐Substituted Acridine Derivatives as Dual Anticancer and Antimicrobial Agents

  2024cites this paper
• Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum

  2024cites this paper
• Synthesis, design, and optimization of a potent and selective series of pyridylpiperazines as promising antimalarial agents.

  2024cites this paper
• Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV-1 CCR5.

  2024cites this paper
• Chemical, antimicrobial, antioxidant, and molecular dynamic studies of spiro[chromane-3',2''-thiopyran]-4'-one 1''-oxide and spiro[chromane-3',2''-thiopyran]-4'-one 1'',1''-dioxide

  2024cites this paper
• Synthesis and toxicity of monothiooxalamides against human red blood cells, brine shrimp (Artemia salina), and fruit fly (Drosophilamelanogaster)

  2024cites this paper
• Click synthesis, anticancer and molecular docking evaluation of some hexahydro-6H-indolo[2,3-b]quinoxalines incorporated triazole moiety

  2024cites this paper
• Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review.

  2024cites this paper
• Advancing Drug Delivery Paradigms: Polyvinyl Pyrolidone (PVP)-Based Amorphous Solid Dispersion for Enhanced Physicochemical Properties and Therapeutic Efficacy

  2024cites this paper
• The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid β levels in Alzheimer's disease model mice.

  2024cites this paper
• Assessment of the in vitro anti-diabetic activity with molecular dynamic simulations of limonoids isolated from Adalia lemon peels

  2024cites this paper
• Structural Simplification of Osimertinib to elaborate new indolyle-pyrimidine-5-carbonitrile derivatives with Anti-proliferative and Anti-SARS-CoV-2 activities assisted by molecular dynamic simulation

  2024cites this paper
• Targeting Cancer with Novel Tetra-1,2,3-Triazole hybrids: Synthesis, Biological Evaluation, and Molecular Dynamics

  2024cites this paper
• Sterols and flavonoids in strawberry calyx with free radical scavenging, anti-inflammatory, and molecular dynamic study

  2023cites this paper
• Acetyl barlerin from Barleria trispinosa induces chemopreventive NQO1 and attenuates LPS-induced inflammation: in vitro and molecular dynamic studies

  2023cites this paper
• Cross-species drug metabolism and impact of metabolic stability testing under anaerobic condition on predicting pharmacokinetics of keto-enol containing compound in humans.

  2023cites this paper
• Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners.

  2023cites this paper
• Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis

  2023cites this paper
• Hit-to-lead optimization of a pyrazinylpiperazine series against Leishmania infantum and Leishmania braziliensis.

  2023cites this paper
• New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies

  2023cites this paper
• Biological activity of 1,2,3-triazole-2-amino-1,4-naphthoquinone derivatives and their evaluation as therapeutic strategy for malaria control.

  2023cites this paper
• Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.

  2022cites this paper
• Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.

  2022cites this paper
• Novel MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine

  2022cites this paper
• The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021.

  2022cites this paper
• Discovery, Optimization, and Evaluation of Potent and Selective PI3Kδ-γ Dual Inhibitors for the Treatment of B-cell Malignancies.

  2022cites this paper
• Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer.

  2022cites this paper
• Anti‐Candida, docking studies, and in vitro metabolism‐mediated cytotoxicity evaluation of Eugenol derivatives

  2022cites this paper
• Publisher Correction: MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine

  2022cites this paper
• A discovery biotransformation strategy: combining in silico tools with high-resolution mass spectrometry and software-assisted data analysis for high-throughput metabolism

  2022influential citation
• Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors.

  2022cites this paper
• Single-Cell Multiomics Analysis for Drug Discovery

  2021cites this paper
• The influence of calculated physicochemical properties of compounds on their ADMET profiles.

  2021cites this paper
• Pharmacokinetics aspects of structural modifications in drug design and therapy

  2021cites this paper
• Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases.

  2021cites this paper
• Discovery ofCYR715:Anovel carboxylic acid-containing soluble guanylate cyclase stimulator.

  2021cites this paper
• Fets et al . – MOG analogues 1 Development of novel MOG analogues with increased stability to explore 1 MCT 2 and α-ketoglutarate biology in vivo 2 3

  2021cites this paper
• Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist.

  2021cites this paper
• Understanding performance of 3D-printed sorbent in study of metabolic stability.

  2020cites this paper
• Probing the dual inhibitory mechanisms of novel thiophenecarboxamide derivatives against Mycobacterium tuberculosis PyrG and PanK: an insight from biomolecular modeling study

  2020cites this paper
• Discovery of a novel selective water-soluble SMAD3 inhibitor as an antitumor agent.

  2020cites this paper
• Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization.

  2020cites this paper
• Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands

  2020cites this paper
• The Derivation of a Matched Molecular Pairs Based ADME/Tox Knowledge Base for Compound Optimization

  2020cites this paper
• Predicting liver cytosol stability of small molecules

  2020cites this paper
• Late Stage Lead Diversification (LSLD) Coupled with Quantitative NMR Spectroscopy to Identify New SAR Vectors at Nanomole Scale Synthesis: Application to Loratadine a Human Histamine H1 Receptor Inverse Agonist.

  2020cites this paper
• Chemoselective Perfluoromethylation of Thio- and Selenoamides.

  2020cites this paper
• Stimuli-Responsive Rifampicin-Based Macromolecules

  2020cites this paper
• Strategies to optimize drug half-life in lead candidate identification

  2019cites this paper
• Impact of the wastewater-mixing zone on attenuation of pharmaceuticals in natural waters: Implications for an impact zone inclusive environmental risk assessment.

  2019cites this paper
• Discovery of GSK3527497: A candidate for the inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4).

  2019cites this paper
• Natural chromones as potential anti-inflammatory agents: Pharmacological properties and related mechanisms.

  2019cites this paper
• Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors.

  2019cites this paper
• An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.

  2019cites this paper
• Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS.

  2019cites this paper
• A preliminary investigation using unnatural amino acids to stabilise peptide radiotracers

  2019cites this paper
• Novel Electrotopological Atomic Descriptors for the Prediction of Xenobiotic Cytochrome P450 Reactions

  2019cites this paper
• Metabolic stability and its role in the discovery of new chemical entities

  2019cites this paper
• The design and synthesis of drug-like trypanosome alternative oxidase inhibitors for the treatment of African trypanosomiasis

  2019cites this paper
• Lipophilic Metabolic Efficiency (LipMetE) and Drug Efficiency Indices to Explore the Metabolic Properties of the Substrates of Selected Cytochrome P450 Isoforms

  2019cites this paper
• Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.

  2018cites this paper
• Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition† †Electronic supplementary information (ESI) available: Supplemental results (Fig. S1–S13 and Tables S1–S10). Crystallography data collection and refinement statistics. Experimental section. Detailed compound s

  2018cites this paper
• Where Do Recent Small Molecule Clinical Development Candidates Come From?

  2018cites this paper
• Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors.

  2018cites this paper
• Novel, potent, selective and brain penetrant vasopressin 1b receptor antagonists.

  2018cites this paper
• Synthesis of 2-alkylthio-N-(quinazolin-2-yl)benzenesulfonamide derivatives: anticancer activity, QSAR studies, and metabolic stability

  2018cites this paper
• Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship study.

  2018cites this paper
• Exploring Palladium-Mediated 11C/12C-Carbonylation Reactions : PET Tracer Development Targeting the Vesicular Acetylcholine Transporter

  2017cites this paper
• Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide.

  2017cites this paper
• Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

  2017cites this paper
• Physicochemical and Biopharmaceutical Factors Affecting Hepatic/Intestinal First-Pass Effect

  2017cites this paper
• The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.

  2017cites this paper
• Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis.

  2016cites this paper
• Metabolic Stability Methods

  2016cites this paper
• Mouse tissue distribution and persistence of the food-born fusariotoxins Enniatin B and Beauvericin.

  2016cites this paper
• Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.

  2016cites this paper
• Synthesis, characterisation and in vitro investigation of photodynamic activity of 5-(4-octadecanamidophenyl)-10,15,20-tris(N-methylpyridinium-3-yl)porphyrin trichloride on HeLa cells using low light fluence rate.

  2016cites this paper
• From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective.

  2016cites this paper
• Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.

  2016cites this paper
• A Pharmacokinetic Modeling Approach to Predict the Contribution of Active Metabolites to Human Efficacious Dose

  2016cites this paper